ACADIA Pharmaceuticals Inc (ACAD) Insider Trading
- $578,210,290.42
- $97,335,442.43
- March 26, 2025
- Stephen Davis
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
April 10, 2023 | Insider | 523 | $18.14 | Sell | $9,487.22 | |
April 6, 2023 | EVP | 1,456 | $18.16 | Sell | $26,440.96 | |
April 6, 2023 | CEO | 8,582 | $18.16 | Sell | $155,849.12 | |
April 6, 2023 | CFO | 1,916 | $18.16 | Sell | $34,794.56 | |
April 6, 2023 | Insider | 701 | $18.16 | Sell | $12,730.16 | |
April 6, 2023 | COO | 1,751 | $18.16 | Sell | $31,798.16 | |
Feb. 24, 2023 | Insider | 350 | $18.78 | Sell | $6,573.00 | |
Feb. 24, 2023 | COO | 461 | $18.78 | Sell | $8,657.58 | |
Feb. 24, 2023 | CEO | 3,851 | $18.78 | Sell | $72,321.78 | |
Feb. 24, 2023 | CFO | 577 | $18.78 | Sell | $10,836.06 | |
Feb. 24, 2023 | EVP | 803 | $18.78 | Sell | $15,080.34 | |
Jan. 12, 2023 | Director | 12,500 | $18.25 | Sell | $228,125.00 | |
Jan. 9, 2023 | EVP | 589 | $17.13 | Sell | $10,089.57 | |
Jan. 9, 2023 | COO | 532 | $17.13 | Sell | $9,113.16 | |
Jan. 9, 2023 | CEO | 3,904 | $17.13 | Sell | $66,875.52 | |
Nov. 21, 2022 | President | 1,847 | $15.07 | Sell | $27,834.29 | |
Oct. 15, 2022 | CEO | 2,804 | $15.81 | Sell | $44,331.24 | |
Oct. 15, 2022 | President | 1,326 | $15.81 | Sell | $20,964.06 | |
May 2, 2022 | President | 2,865 | $18.18 | Sell | $52,085.70 | |
May 2, 2022 | EVP | 894 | $18.18 | Sell | $16,252.92 | |
May 2, 2022 | CEO | 5,483 | $18.18 | Sell | $99,680.94 | |
May 2, 2022 | COO | 552 | $18.18 | Sell | $10,035.36 | |
April 8, 2022 | insider | 1,025 | $27.05 | Sell | $27,726.25 | |
Feb. 23, 2022 | Insider | 359 | $23.80 | Sell | $8,544.20 | |
Feb. 23, 2022 | CEO | 3,928 | $23.80 | Sell | $93,486.40 | |
Feb. 23, 2022 | EVP | 782 | $23.80 | Sell | $18,611.60 | |
Feb. 23, 2022 | COO | 472 | $23.80 | Sell | $11,233.60 | |
Feb. 23, 2022 | President | 1,501 | $23.80 | Sell | $35,723.80 | |
Nov. 22, 2021 | President | 2,803 | $19.01 | Sell | $53,285.03 | |
Oct. 18, 2021 | CEO | 2,963 | $17.41 | Sell | $51,585.83 | |
Oct. 18, 2021 | President | 1,338 | $17.41 | Sell | $23,294.58 | |
April 30, 2021 | CFO | 1,032 | $20.33 | Sell | $20,980.56 | |
April 30, 2021 | CEO | 7,850 | $20.33 | Sell | $159,590.50 | |
April 30, 2021 | EVP | 1,054 | $20.33 | Sell | $21,427.82 | |
April 30, 2021 | President | 4,230 | $20.33 | Sell | $85,995.90 | |
Feb. 4, 2021 | CEO | 14,195 | $50.61 | Sell | $718,408.95 | |
Feb. 4, 2021 | EVP | 2,107 | $50.61 | Sell | $106,635.27 | |
Feb. 4, 2021 | President | 8,429 | $50.61 | Sell | $426,591.69 | |
Feb. 4, 2021 | CFO | 2,051 | $50.61 | Sell | $103,801.11 | |
Jan. 12, 2021 | President | 700 | $55.01 | Sell | $38,507.00 | |
Jan. 8, 2021 | President | 29,733 | $55.22 | Sell | $1,641,856.26 | |
Jan. 6, 2021 | CFO | 1,016 | $53.34 | Sell | $54,193.44 | |
Jan. 6, 2021 | EVP | 1,120 | $53.34 | Sell | $59,740.80 | |
Jan. 6, 2021 | President | 1,725 | $53.34 | Sell | $92,011.50 | |
Jan. 6, 2021 | CEO | 3,484 | $53.34 | Sell | $185,836.56 | |
Nov. 20, 2020 | President | 2,728 | $53.50 | Sell | $145,948.00 | |
Oct. 27, 2020 | EVP | 8,750 | $45.10 | Sell | $394,625.00 | |
Oct. 16, 2020 | EVP | 1,247 | $42.56 | Sell | $53,072.32 | |
Oct. 16, 2020 | President | 1,297 | $42.56 | Sell | $55,200.32 | |
Oct. 16, 2020 | CEO | 2,960 | $42.56 | Sell | $125,977.60 |
Insiders are both buying and selling ACADIA Pharmaceuticals Inc stock.
The insider traders at ACADIA Pharmaceuticals Inc are: Stephen Davis, Srdjan R Stankovic, James Kihara, Mark C Schneyer, Brendan Teehan, Glenn Baity, Uli Hacksell, Austin D Kim, Bros. Advisors Lp Baker, Laura Brege, Michael J Yang, Elena Ridloff, Torsten Rasmussen, William Mcdowall Wells, Eric Alejandro Miller, Austin D. Kim, Mary Ann Gray, James M Daly, Michael T Borer, Roger Mills, Felix Baker, Thomas Aasen, Thomas H Aasen, Leslie L. Iversen, Edmund Harrigan, Srdjan R. Stankovic, Lester Ph Kaplan, L.P. 14159, Leslie L Iversen, Elizabeth A Garofalo, Terrence O. Moore, Michael J. Yang, and Daniel B Soland
The most active insider trader at ACADIA Pharmaceuticals Inc is Stephen Davis with 26 trades.
Stephen Davis has sold the most ACADIA Pharmaceuticals Inc stock with a total value of $23,353,349.94.
Bros. Advisors Lp Baker has bought the most ACADIA Pharmaceuticals Inc stock with a total value of $449,849,410.39.
The most recent insider trade for ACADIA Pharmaceuticals Inc was on March 26, 2025.
The single biggest insider buy for ACADIA Pharmaceuticals Inc was from Bros. Advisors Lp Baker with a total value of $199,999,985.00 on Nov. 30, 2018.
The single biggest insider sell for ACADIA Pharmaceuticals Inc was from Stephen Davis with a total value of $7,851,000.00 on Dec. 5, 2019.